Skip to main content

Table 1 Clinical data of patients

From: One-stage posterior surgery combined with anti-Brucella therapy in the management of lumbosacral brucellosis spondylitis: a retrospective study

Patient

Age (range, year)

Gender (M/F)

Affected level

Pathogen

Extra-spine infestation

Postoperative grade of FC

Follow-up time (year)

Outcome

1

40–45

M

L2–L3

BM

Fever

E

4

FOD

2

27–32

M

L3–L5

BA

Fever + S

E

3

FOD

3

45–50

F

L4–L5

BM

Fever + H + S

C

3

ND

4

45–50

M

L2–L4

Neg

Fever

E

2

FOD

5

30–35

M

L2–L3

BM

Fever

E

3

FOD

6

32–37

M

L4–L5

BM

Fever

E

5

FOD

7

40–45

M

L2–L3

BM

Fever

E

3

FOD

8

45–50

M

T12–L3

BM

Fever

E

4

FOD

9

35–40

M

L4–L5

BM

Fever

E

2

FOD

10

50–55

F

L5–S1

BA

Fever + H

E

5

FOD

11

40–45

M

L2–L4

BM

Fever

E

3

FOD

12

47–52

M

L3–L4

Neg

Fever

E

2

FOD

13

45–50

F

L3–L5

BM

Fever + H

E

2

FOD

14

35–40

M

T11–L2

BA

Fever + H + S

D

4

FOD

15

40–45

M

L3–L5

BM

Fever

E

2

FOD

16

32–37

M

L4–L5

Neg

Fever + H

E

3

FOD

17

40–45

M

L5–S1

Neg

Fever + H + S

C

4

ND

18

40–45

F

T10–L2

BM

Fever

E

2

FOD

19

40–45

M

L3–L5

BM

Fever + H

E

3

FOD

20

40–45

M

L3

BA

Fever

E

2

FOD

21

30–35

M

S1

BM

Fever

E

5

FOD

22

40–45

F

L5–S1

BM

Fever

E

4

FOD

23

45–50

M

L4–L5

BS

Fever

E

2

FOD

24

42–47

F

L1–L4

BM

Fever

E

2

FOD

25

50–60

M

L3

BA

Fever + H

E

3

FOD

26

42–47

M

L5–S1

BM

Fever

E

2

FOD

27

35–40

M

L3

BM

Fever + H + S

D

2

FOD

28

35–40

M

L5

Neg

Fever + H

E

4

FOD

29

45–50

M

L1–L3

BM

Fever

E

3

FOD

30

32–37

F

T12

BM

Fever

E

2

FOD

31

40–45

M

L2–L3

Neg

Fever

E

3

FOD

32

35–40

F

T12

BM

Fever

E

2

FOD

33

25–30

M

L1–L2

BM

Fever + H

E

4

FOD

34

38–42

M

L2–L4

BM

Fever

E

2

FOD

35

35–40

M

T12–L2

BM

Fever + H + S

E

3

FOD

36

38–42

F

L1–L3

Neg

Fever

E

2

FOD

37

35–40

M

L4–L5

BM

Fever

E

4

FOD

38

25–30

F

L5–S1

BM

Fever + H

E

3

FOD

39

25–30

F

T12–L2

Neg

Fever

E

5

FOD

40

30–35

M

L3–L5

BM

Fever

E

2

FOD

41

45–50

M

T12

BM

Fever + H + S

E

3

FOD

42

42–47

M

S1–S2

BM

Fever + H

E

3

FOD

43

52–57

M

L5–S1

BM

Fever

E

4

FOD

44

42–47

M

L2–L3

Neg

Fever

E

3

FOD

45

35–40

F

T12–L2

BM

Fever

E

3

FOD

46

32–37

M

L4–L5

BM

Fever + H

E

2

FOD

47

45–50

F

L4–L5

BM

Fever + H + S

E

3

FOD

48

30–35

F

T12–L2

BM

Fever + H + S

E

4

FOD

49

40–45

M

L2–L3

Neg

Fever + H + S

E

3

FOD

50

40–45

M

L3–L5

BM

Fever + H

E

2

FOD

51

45–50

M

L5–S1

Neg

Fever

E

4

FOD

52

45–50

F

T12–L2

BM

Fever

E

3

FOD

53

40–45

M

L2–L3

Neg

Fever

E

3

FOD

54

30–35

M

L2–L4

BM

Fever

E

2

FOD

55

28–32

M

L5

BM

Fever + H

E

5

FOD

  1. BA, Brucella abortus; BM, Brucella melitensis; BS, Brucella suis; F, female; FOD, free of disease; H, hepatomegaly; M, male; Neg, negative; ND, neurological dysfunction; S, splenomegaly